<!DOCTYPE html>
<html lang="en-US"><head>
		<meta charset="UTF-8">
		<title>FR940725-2-00071</title>
	</head>
	<body>
		<main>
			<p><!-- PJG STAG 4703 -->  <!-- PJG ITAG l=11 g=1 f=1 -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> Application Procedures:  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> Grant application kits (including Form PHS 5161&hyph;1, with Standard Form 424 and complete application procedures) may be obtained from: National Clearinghouse for Alcohol &amp; Drug Information, P.O. Box 2345, Rockville, Maryland 20847&hyph;2345, 1&hyph;800&hyph;729&hyph;6686. <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Applicants must submit: (1) an original copy signed by the authorized official of the applicant organization, with the appropriate appendices; and (2) two additional, legible copies of the application and all appendices to the following address: Center for Substance Abuse Treatment Programs, Division of Research Grants, NIH, Westwood Building, room 240, 5333 Westbard Avenue, Bethesda, Maryland 20892.* <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <FOOTNOTE> <!-- PJG ITAG l=28 g=1 f=1 --> *If an overnight carrier or express mail is used, the Zip Code is 20816.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> </FOOTNOTE>  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> Review Process:  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> Applications submitted in response to this announcement will be reviewed for technical merit in accordance with established PHS/SAMHSA peer review procedures for grants.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> Applications that are accepted for review will be assigned to an Initial Review Group (IRG) composed primarily of non-Federal experts. Notification of the IRG's recommendation will be sent to the applicant upon completion of the review. <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=83 g=1 f=1 --> Review Criteria <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=81 g=1 f=1 --> 1. Potential Significance (30%)  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> The extent to which the proposed conference has potential regional or national significance for the field of drug abuse treatment.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=81 g=1 f=1 --> 2. Approach (20%)  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> Clarity and justification of overall goals, objectives, and approach of the conference. Feasibility of the conference agenda/content and relevance to CSAT mission to improve the delivery of substance abuse treatment and recovery services. Extent to which proposal supports inter-agency collaboration. Adequacy of plan for conference product (proceedings, manual, report).  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=81 g=1 f=1 --> 3. Resources and Management (20%)  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> Manner in which the conference is planned and organized. Presence of an administrative and organizational structure that will facilitate attainment of the proposed objective(s) of the conference. Capability/experience of the proposed conference director and other key personnel. Participation of appropriate speakers, presenters or participants. Adequacy of previous reports of conferences (if any) produced by the applicant.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=81 g=1 f=1 --> 4. Budget (25%)  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> Cost effectiveness and reasonableness of overall project cost relative to planned activities. Appropriateness of budget breakouts and line item justifications.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=81 g=1 f=1 --> 5. Evaluation (5%)  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> Clarity/feasibility/appropriateness of proposed plan for evaluation of conference planning, content and outcome, including the production of the required conference product.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> Award Decision Criteria:  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> Applications will be considered for funding on the basis of overall technical merit of the project as determined through the review process. Other criteria will include:  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> 1. Potential for knowledge dissemination, interface with health promotion concepts and practices, promotion of resource utilization and/or consensus building.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> 2. Relevance to the CSAT/SAMHSA priorities addressed by the National Drug Control Strategy (e.g., women and their children, hard core abusers, relationship between alcohol/drug abuse and violence, service needs/delivery within the criminal justice system, comorbidity or the provision of mental health services as part of addictions treatment, health care reform).  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> 3. Programmatic balance (focus upon differing problems of drug treatment, including the issues of cultural sensitivity, HIV/AIDS, sexually transmitted diseases, and tuberculosis.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> 4. Innovative conferences/conferencing techniques (e.g., teleconferencing, Delphi Computer conferencing).  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> 5. Geographic balance.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> 6. Availability of funds. <!-- PJG /ITAG -->  <!-- PJG QTAG 02 --> <!-- PJG /QTAG -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG ITAG l=10 g=1 f=2 --> CONTACTS FOR ADDITIONAL INFORMATION:  <!-- PJG /ITAG -->  <!-- PJG ITAG l=10 g=1 f=1 --> Questions concerning program issues may be directed to: Susanne R. Rohrer, R.N., Office of Scientific Analysis and Evaluation, Center for Substance Abuse Treatment, Rockwall II Building, 10th Floor, 5600 Fishers Lane, Rockville, Maryland 20857, (301) 443&hyph;8831. <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> Questions regarding grants management issues may be directed to:  <!-- PJG 0012 frnewline --> Grants Management Office, Center for Substance Abuse Treatment, Rockwall II Building, 10th Floor, 5600 Fishers Lane, Rockville, Maryland 20857, (301) 443&hyph;6533. <!-- PJG /ITAG -->  <!-- PJG QTAG 04 --> <!-- PJG /QTAG -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG ITAG l=21 g=1 f=1 --> Dated: July 18, 1994.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <SIGNER> <!-- PJG ITAG l=06 g=1 f=1 --> Richard Kopanda, <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG --> </SIGNER> <SIGNJOB> <!-- PJG ITAG l=04 g=1 f=1 --> Acting Executive Officer, SAMHSA. <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG --> </SIGNJOB> <FRFILING> <!-- PJG ITAG l=40 g=1 f=1 --> [FR Doc. 94&hyph;18050 Filed 7&hyph;22&hyph;94; 8:45 am]  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG --> </FRFILING> <BILLING> <!-- PJG ITAG l=68 g=1 f=1 --> BILLING CODE 4162&hyph;20&hyph;P  <!-- PJG /ITAG --> </BILLING>  <!-- PJG 0012 frnewline -->  <!-- PJG /STAG --></p>
		</main>
</body></html>
            